RxDoctor Payments Data

Andrew Trobridge, MD

Pain Medicine · Muncie, INNPI 1912965849

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $203,986 of the $253,408 with a category attached, or 80.5%. Stryker accounts for 70.7% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2021 at $53,393 and has fallen 77.1% since, to $12,214 in 2025. Among pain medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$253,408in general payments, 2019–2025

Across 334 payments — averaging $758.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$179K
  • Omnia Medical, LLC$26K
  • Choice Spine, LLC$26K
  • Spinal Simplicity, LLC$10K
  • MML US, Inc.$3K
  • Boston Scientific$2K
  • plus $8K from 31 others
$12,841in research payments, 2019–2025

Across 10 payments — averaging $1284.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Si-bone, Inc.$8K
  • Spinal Simplicity, LLC$5K

What the payments were for

  • Consulting fees$203,98680%
  • Travel & lodging$30,45912%
  • Food & beverage$14,9636%
  • Education$4,0002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$253,408 in reported general payments places this provider in the 95th percentile of 128 pain medicine providers in Indiana.

See all pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$339,594
Medicare patients
402
Services billed
4,300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen412$13,004
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen620$10,970
Gabapentin234$3,934
Morphine Sulfate ErMorphine Sulfate131$3,383
Pregabalin92$2,776
Naloxone Hcl52$2,433
Fentanyl15$1,425
Oxycodone Hcl71$1,177
Tramadol Hcl89$704
Tizanidine Hcl87$597
Mupirocin85$552
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim84$409
Cyclobenzaprine Hcl38$340
Hydromorphone Hcl16$273
Methadone Hcl12$165

Paid to pharmacies, not to this prescriber.

Other pain medicine in Muncie

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →